8 terminated. 8 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 8 | Terminated 8 |
| Phase 1 | 1 | Terminated 1 |
| Phase 3 | 1 | Terminated 1 |
Follow Glutamine: new trials by email Literature Review of Glutamine trials Research Report on Glutamine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treatment of Adults With Generalized Anxiety Disorder Using Glutamine L Glutamine, Placebos - Generalized Anxiety Disorder | Phase 2 | Terminated | Hospital Universitario Dr. Jose E. Gonzalez | 38 | 2019-01-18 | 2021-02-11 |
| Lenalidomide Combined With Vorinostat/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Diffuse Large B-Cell Lymphoma of the ABC Subtype Lenalidomide, Vorinostat, Gemcitabine - Lymphoma | Phase 1 / Phase 2 | Terminated | M.D. Anderson Cancer Center | 8 | 2016-06-22 | 2019-12-13 |
| Glutamine for the Prevention of Radiation Toxicity in Subjects Conserving Therapy Glutamine, Placebo - Breast Cancer | Phase 2 | Terminated | University of Arkansas | 14 | 2014-06-01 | 2019-05-29 |
| Glutamine in Preventing Peripheral Neuropathy in Patients With Multiple Myeloma Receiving Bortezomib glutamine, quality-of-life assessment, placebo - Chemotherapeutic Agent Toxicity, Multiple Myeloma | Phase 2 | Terminated | Beth Faiman | 9 | 2013-02-01 | 2019-10-22 |
| A Randomized Double-Blind Control-Comparison Crossover Trial of Oral Glutamine to Suppress Frequently Recurrent Herpes Labialis Glutamine, Glycine - Herpes Labialis, Herpes Simplex Virus | Phase 2 | Terminated | National Institute of Allergy and Infectious Diseases (NIAID) | 11 | 2009-06-01 | 2012-06-11 |
| Enteral Glutamine in Critical Illness Glutamine - Critical Illness, Sepsis | Phase 2 / Phase 3 | Terminated | Christiana Care Health Services | 20 | 2006-05-01 | 2008-03-13 |
| Trial of Oral Glutamine in Patients With Sickle Cell Anemia Glutamine, Placebo - Anemia, Sickle Cell | Phase 2 | Terminated | St. Jude Children's Research Hospital | 27 | 2004-05-01 | 2017-04-26 |
| L-Glutamine Therapy for Sickle Cell Anemia L-Glutamine, Placebo - Sickle Cell Anemia, Thalassemia | Phase 2 | Terminated | Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | 15 | 2004-02-06 | 2021-02-02 |
Anemia, Sickle Cell (2) · Breast Neoplasms (1) · Critical Illness (1) · Generalized Anxiety Disorder (1) · Herpes Labialis (1) · Herpes Simplex (1) · Lymphoma (1) · Lymphoma, Large B-Cell, Diffuse (1) · Multiple Myeloma (1) · Peripheral Nervous System Diseases (1) · Respiratory Insufficiency (1) · Sepsis (1) · Thalassemia (1)
Beth Faiman (1) · Christiana Care Health Services (1) · Hospital Universitario Dr. Jose E. Gonzalez (1) · Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center (1) · M.D. Anderson Cancer Center (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · St. Jude Children's Research Hospital (1) · University of Arkansas (1)
United States (7) · Mexico (1)
Beth Faiman (1) · Loverd Peacock, MD (1) · Michael DePietro, M.D. (1) · Ruth Williams, MS, RD, EdD (1) · Yago Nieto, MD, PHD (1) · Yihong Kaufmann, PhD (1) · Yutaka Niihara, MD (1)